Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing

Proximal spinal muscular atrophy (SMA) is caused by mutations in the surviv al motor neuron gene (SMN1). In humans, two nearly identical copies of SMN exist and differ only by a single non-polymorphic C -->T nucleotide transit ion in exon 7. SMN1 contains a 'C' nucleotide at the +6 position of exon 7 and produces primarily full-length SMN transcripts, whereas SMN2 contains a 'T' nucleotide and produces high levels of a transcript that lacks exon 7 and a low level of full-length SMN transcripts. All SMA patients lack a fun ctional SMN1 gene but retain at least one copy of SMN2, suggesting that the low level of full-length protein produced from SMN2 is sufficient for all cell types except motor neurons. The murine Smn gene is not duplicated or a lternatively spliced. It resembles SMN1 in that the critical exon 7 +6 'C' nucleotide is conserved. We have generated Smn minigenes containing either wild-type Smn exon 7 or an altered exon 7 containing the C -->T nucleotide transition to mimic SMN2. When expressed in cultured cells or transgenic mi ce, the wild-type minigene produced only full-length transcripts whereas th e modified minigene alternatively spliced exon 7. Furthermore, Smn exon 7 c ontains a critical AG-rich exonic splice enhancer sequence (ESE) analogous to the human ESE within SMN exon 7, and subtle mutations within the mESE ca used a variation in Smn transcript levels. In summary, we show for the firs t time that the murine Smnlocus can be induced to alternatively splice exon 7. These results demonstrate that SMN protein levels can be varied in the mouse by the introduction of specific mutations at the endogenous Smn locus and thereby lay the foundation for developing animals that closely 'resemb le' SMA patients.